| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.711 | 0.007 | 0.711 | Cholesterol antagonist | 0.599 0.019 DBMET01973 | ||
| 0.698 | 0.006 | 0.698 | Spasmolytic | 0.303 0.069 DBMET01973 | ||
| 0.649 | 0.013 | 0.649 | Aldehyde oxidase inhibitor | 0.395 0.048 DBMET01973 | ||
| 0.631 | 0.004 | 0.631 | Interleukin 6 antagonist | 0.23 0.028 DBMET01973 | ||
| 0.615 | 0.005 | 0.615 | Cholinergic | 0.561 0.005 DBMET01973 | ||
| 0.61 | 0.015 | 0.61 | Vasodilator, peripheral | 0.373 0.064 DBMET01973 | ||
| 0.566 | 0.004 | 0.566 | Alpha-N-acetylglucosaminidase inhibitor | 0.427 0.008 DBMET01973 | ||
| 0.551 | 0.01 | 0.551 | Vasodilator, coronary | 0.338 0.061 DBMET01973 | ||
| 0.538 | 0.005 | 0.538 | Phospholipase C inhibitor | 0.262 0.023 DBMET01973 | ||
| 0.536 | 0.009 | 0.536 | Vasodilator | |||
| 0.497 | 0.011 | 0.497 | Psychostimulant | 0.241 0.062 DBMET01973 | ||
| 0.503 | 0.029 | 0.503 | Antithrombotic | 0.286 0.098 DBMET01973 | ||
| 0.461 | 0.004 | 0.461 | Alcohol oxidase inhibitor | 0.124 0.014 DBMET01973 | ||
| 0.511 | 0.056 | 0.511 | Caspase 9 stimulant | 0.423 0.098 DBMET01973 | ||
| 0.454 | 0.013 | 0.454 | Platelet aggregation inhibitor | |||
| 0.464 | 0.037 | 0.511 | GABA C receptor rho-3 antagonist | 0.511 0.023 DBMET01973 | DBMET01973 | |
| 0.421 | 0.006 | 0.421 | Anesthetic local | 0.199 0.032 DBMET01973 | ||
| 0.412 | 0.004 | 0.412 | Telomerase inhibitor | 0.112 0.029 DBMET01973 | ||
| 0.427 | 0.024 | 0.427 | Cardiotonic | |||
| 0.406 | 0.01 | 0.406 | Cytidine deaminase inhibitor | 0.197 0.049 DBMET01973 | ||
| 0.409 | 0.02 | 0.409 | Angiogenesis stimulant | |||
| 0.427 | 0.05 | 0.427 | Toll-Like receptor agonist | |||
| 0.379 | 0.008 | 0.392 | Acetylcholinesterase inhibitor | 0.392 0.007 DBMET01973 | DBMET01973 | |
| 0.369 | 0.002 | 0.369 | Acetylcholine M3 receptor agonist | 0.312 0.002 DBMET01973 | ||
| 0.419 | 0.053 | 0.419 | Toll-Like receptor 7 agonist | |||
| 0.385 | 0.023 | 0.385 | Peroxidase inhibitor | 0.266 0.044 DBMET01973 | ||
| 0.363 | 0.006 | 0.363 | GABA C receptor agonist | 0.322 0.008 DBMET01973 | ||
| 0.402 | 0.045 | 0.402 | 5 Hydroxytryptamine release stimulant | 0.366 0.053 DBMET01973 | ||
| 0.421 | 0.068 | 0.421 | Antibacterial | 0.275 0.155 DBMET01973 | ||
| 0.376 | 0.034 | 0.376 | DNA damaging | 0.25 0.08 DBMET01973 | ||
| 0.387 | 0.048 | 0.387 | Immunomodulator | |||
| 0.421 | 0.083 | 0.481 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.481 0.043 DBMET01973 | DBMET01973 | |
| 0.34 | 0.002 | 0.34 | Acetylcholine M2 receptor agonist | 0.238 0.003 DBMET01973 | ||
| 0.341 | 0.009 | 0.341 | Growth factor agonist | |||
| 0.339 | 0.009 | 0.339 | Acetylcholine M1 receptor antagonist | 0.209 0.039 DBMET01973 | ||
| 0.403 | 0.076 | 0.403 | 5 Hydroxytryptamine release inhibitor | 0.394 0.081 DBMET01973 | ||
| 0.344 | 0.02 | 0.344 | Hepatoprotectant | |||
| 0.378 | 0.056 | 0.378 | Immunostimulant | 0.193 0.124 DBMET01973 | ||
| 0.328 | 0.011 | 0.328 | Adenylate cyclase inhibitor | 0.185 0.029 DBMET01973 | ||
| 0.337 | 0.026 | 0.337 | Anesthetic general | 0.249 0.051 DBMET01973 | ||
| 0.323 | 0.012 | 0.323 | Cholinergic antagonist | 0.169 0.043 DBMET01973 | ||
| 0.312 | 0.013 | 0.312 | Acetylcholine antagonist | 0.165 0.043 DBMET01973 | ||
| 0.302 | 0.004 | 0.302 | Potassium channel large-conductance Ca-activated activator | 0.127 0.015 DBMET01973 | ||
| 0.318 | 0.025 | 0.318 | Tyrosine 3 hydroxylase inhibitor | 0.302 0.032 DBMET01973 | ||
| 0.305 | 0.012 | 0.305 | Alkylator | 0.197 0.027 DBMET01973 | ||
| 0.312 | 0.021 | 0.312 | Peptidyltransferase inhibitor | |||
| 0.326 | 0.036 | 0.326 | DNA synthesis inhibitor | 0.264 0.058 DBMET01973 | ||
| 0.296 | 0.009 | 0.296 | Acetylcholine muscarinic antagonist | 0.17 0.034 DBMET01973 | ||
| 0.288 | 0.01 | 0.288 | Cell wall synthesis inhibitor | 0.202 0.029 DBMET01973 | ||
| 0.278 | 0.004 | 0.278 | Sphingomyelinase inhibitor | 0.206 0.009 DBMET01973 | ||
| 0.28 | 0.014 | 0.28 | Succinate dehydrogenase inhibitor | 0.23 0.03 DBMET01973 | ||
| 0.304 | 0.048 | 0.304 | Hypolipemic | |||
| 0.354 | 0.098 | 0.354 | Histamine release inhibitor | 0.296 0.125 DBMET01973 | ||
| 0.297 | 0.051 | 0.297 | Superoxide dismutase inhibitor | 0.212 0.105 DBMET01973 | ||
| 0.266 | 0.02 | 0.266 | Phospholipase A2 inhibitor | 0.137 0.09 DBMET01973 | ||
| 0.249 | 0.004 | 0.249 | Interferon agonist | 0.099 0.029 DBMET01973 | ||
| 0.248 | 0.007 | 0.248 | Triose-phosphate isomerase inhibitor | 0.225 0.008 DBMET01973 | ||
| 0.245 | 0.005 | 0.245 | Vanilloid agonist | |||
| 0.247 | 0.008 | 0.247 | Potassium channel (Ca-activated) activator | 0.149 0.028 DBMET01973 | ||
| 0.243 | 0.006 | 0.243 | Creatine kinase inhibitor | 0.143 0.027 DBMET01973 | ||
| 0.243 | 0.014 | 0.243 | UDP-glucose 4-epimerase inhibitor | 0.181 0.021 DBMET01973 | ||
| 0.361 | 0.133 | 0.361 | Apoptosis agonist | |||
| 0.235 | 0.006 | 0.235 | Vanilloid 1 agonist | 0.168 0.024 DBMET01973 | ||
| 0.263 | 0.037 | 0.263 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.22 0.058 DBMET01973 | ||
| 0.23 | 0.008 | 0.23 | Interleukin 8 antagonist | 0.155 0.031 DBMET01973 | ||
| 0.275 | 0.053 | 0.282 | Gastrin inhibitor | 0.282 0.047 DBMET01973 | DBMET01973 | |
| 0.279 | 0.057 | 0.32 | 5 Hydroxytryptamine uptake stimulant | 0.32 0.036 DBMET01973 | DBMET01973 | |
| 0.241 | 0.02 | 0.265 | 5 Hydroxytryptamine 3E antagonist | 0.265 0.01 DBMET01973 | DBMET01973 | |
| 0.227 | 0.01 | 0.227 | Acetylcholine nicotinic antagonist | 0.124 0.029 DBMET01973 | ||
| 0.235 | 0.022 | 0.235 | Interleukin 1 antagonist | |||
| 0.224 | 0.017 | 0.283 | Ferrochelatase inhibitor | 0.283 0.009 DBMET01973 | DBMET01973 | |
| 0.234 | 0.03 | 0.234 | Antipruritic | 0.143 0.103 DBMET01973 | ||
| 0.251 | 0.047 | 0.251 | DNA methyltransferase I inhibitor | 0.145 0.109 DBMET01973 | ||
| 0.221 | 0.019 | 0.221 | Nav1.3 sodium channel blocker | 0.14 0.055 DBMET01973 | ||
| 0.215 | 0.013 | 0.215 | Adenylate kinase inhibitor | 0.18 0.018 DBMET01973 | ||
| 0.238 | 0.042 | 0.238 | Nitric-oxide synthase stimulant | 0.229 0.049 DBMET01973 | ||
| 0.204 | 0.01 | 0.204 | NADH dehydrogenase inhibitor | 0.149 0.018 DBMET01973 | ||
| 0.205 | 0.011 | 0.205 | Adenylate cyclase stimulant | 0.2 0.014 DBMET01973 | ||
| 0.203 | 0.012 | 0.203 | GABA C receptor antagonist | 0.179 0.018 DBMET01973 | ||
| 0.313 | 0.123 | 0.313 | 15-Lipoxygenase inhibitor | |||
| 0.198 | 0.011 | 0.198 | Phosphofructokinase-1 inhibitor | 0.148 0.018 DBMET01973 | ||
| 0.21 | 0.024 | 0.217 | GABA C receptor rho-2 antagonist | 0.217 0.021 DBMET01973 | DBMET01973 | |
| 0.209 | 0.024 | 0.209 | Platelet activating factor antagonist | 0.11 0.07 DBMET01973 | ||
| 0.209 | 0.025 | 0.209 | Arachidonic acid antagonist | 0.199 0.034 DBMET01973 | ||
| 0.184 | 0.006 | 0.184 | Acyl-CoA dehydrogenase inhibitor | 0.146 0.009 DBMET01973 | ||
| 0.182 | 0.005 | 0.182 | Acetylcholine release stimulant | 0.137 0.027 DBMET01973 | ||
| 0.181 | 0.008 | 0.181 | Phenylalanine 4-hydroxylase inhibitor | 0.09 0.031 DBMET01973 | ||
| 0.18 | 0.008 | 0.18 | Acetylcholine muscarinic agonist | 0.133 0.012 DBMET01973 | ||
| 0.232 | 0.059 | 0.232 | DNA methylase inhibitor | 0.136 0.131 DBMET01973 | ||
| 0.198 | 0.026 | 0.198 | DNA intercalator | |||
| 0.187 | 0.016 | 0.187 | Acetylcholine agonist | 0.145 0.027 DBMET01973 | ||
| 0.203 | 0.033 | 0.203 | Neurotensin receptor agonist | 0.183 0.047 DBMET01973 | ||
| 0.177 | 0.009 | 0.184 | Carbamoyl phosphate synthetase inhibitor | 0.184 0.008 DBMET01973 | DBMET01973 | |
| 0.203 | 0.035 | 0.213 | ATPase inhibitor | 0.213 0.028 DBMET01973 | DBMET01973 | |
| 0.175 | 0.01 | 0.175 | Ca2+-transporting ATPase inhibitor | 0.17 0.013 DBMET01973 | ||
| 0.163 | 0.004 | 0.163 | Nicotinic receptor alpha4 subunit antagonist | 0.113 0.006 DBMET01973 | ||
| 0.17 | 0.014 | 0.17 | GABA C receptor rho-1 antagonist | 0.164 0.016 DBMET01973 | ||
| 0.179 | 0.025 | 0.341 | Butyrylcholinesterase inhibitor | 0.341 0.008 DBMET01973 | DBMET01973 | |
| 0.239 | 0.087 | 0.239 | Interleukin agonist | 0.188 0.132 DBMET01973 | ||
| 0.163 | 0.012 | 0.163 | Anabolic | 0.15 0.018 DBMET01973 | ||
| 0.221 | 0.073 | 0.248 | RNA-directed DNA polymerase inhibitor | 0.248 0.05 DBMET01973 | DBMET01973 | |
| 0.269 | 0.125 | 0.304 | Calcium channel activator | 0.304 0.088 DBMET01973 | DBMET01973 | |
| 0.189 | 0.044 | 0.189 | Thiol protease inhibitor | 0.181 0.048 DBMET01973 | ||
| 0.184 | 0.04 | 0.184 | Mannose-6-phosphate isomerase inhibitor | 0.149 0.065 DBMET01973 | ||
| 0.146 | 0.005 | 0.146 | Acetylcholine M5 receptor agonist | 0.144 0.005 DBMET01973 | ||
| 0.152 | 0.011 | 0.152 | Acetylcholine M2 receptor antagonist | 0.088 0.025 DBMET01973 | ||
| 0.153 | 0.012 | 0.153 | Aminopeptidase I inhibitor | 0.092 0.032 DBMET01973 | ||
| 0.258 | 0.12 | 0.258 | Sodium/bile acid cotransporter inhibitor | |||
| 0.142 | 0.004 | 0.142 | Phospholipase D inhibitor | 0.107 0.011 DBMET01973 | ||
| 0.171 | 0.033 | 0.216 | Cathepsin H inhibitor | 0.216 0.019 DBMET01973 | DBMET01973 | |
| 0.21 | 0.073 | 0.21 | Amyloid beta aggregation inhibitor | |||
| 0.167 | 0.031 | 0.167 | Aminopeptidase B inhibitor | 0.126 0.049 DBMET01973 | ||
| 0.24 | 0.106 | 0.247 | Insulysin inhibitor | 0.247 0.099 DBMET01973 | DBMET01973 | |
| 0.256 | 0.122 | 0.256 | Apoptosis antagonist | |||
| 0.158 | 0.026 | 0.178 | TRPA1 agonist | 0.178 0.017 DBMET01973 | DBMET01973 | |
| 0.135 | 0.005 | 0.135 | Estrogen-related receptor beta agonist | 0.104 0.021 DBMET01973 | ||
| 0.165 | 0.036 | 0.165 | Antibacterial (Helicobacter pylori) | 0.13 0.067 DBMET01973 | ||
| 0.141 | 0.012 | 0.141 | Bromodomain-containing protein 2 inhibitor | 0.131 0.016 DBMET01973 | ||
| 0.149 | 0.021 | 0.149 | Porphobilinogen synthase inhibitor | 0.138 0.023 DBMET01973 | ||
| 0.137 | 0.009 | 0.137 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.088 0.017 DBMET01973 | ||
| 0.139 | 0.012 | 0.139 | Acetylcholine M4 receptor antagonist | 0.096 0.032 DBMET01973 | ||
| 0.14 | 0.015 | 0.14 | Glutamate decarboxylase inhibitor | 0.108 0.025 DBMET01973 | ||
| 0.143 | 0.017 | 0.143 | Glutamate dehydrogenase inhibitor | 0.131 0.02 DBMET01973 | ||
| 0.155 | 0.03 | 0.155 | Mucolytic | 0.129 0.047 DBMET01973 | ||
| 0.136 | 0.012 | 0.136 | Acetylcholine M3 receptor antagonist | 0.087 0.023 DBMET01973 | ||
| 0.143 | 0.019 | 0.143 | Acetylcholine nicotinic agonist | 0.109 0.031 DBMET01973 | ||
| 0.152 | 0.03 | 0.152 | Carbonic anhydrase XV inhibitor | 0.12 0.046 DBMET01973 | ||
| 0.181 | 0.06 | 0.181 | MAP kinase kinase 5 inhibitor | |||
| 0.288 | 0.168 | 0.342 | Calcium channel L-type activator | 0.342 0.123 DBMET01973 | DBMET01973 | |
| 0.131 | 0.01 | 0.131 | Acetylcholine M5 receptor antagonist | 0.065 0.035 DBMET01973 | ||
| 0.22 | 0.101 | 0.22 | Antioxidant | |||
| 0.13 | 0.013 | 0.13 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.131 | 0.015 | 0.131 | Neuronal nicotinic receptor antagonist | 0.094 0.027 DBMET01973 | ||
| 0.202 | 0.092 | 0.202 | Cyclic AMP phosphodiesterase inhibitor | 0.158 0.138 DBMET01973 | ||
| 0.154 | 0.045 | 0.154 | Aldehyde dehydrogenase inhibitor | 0.129 0.063 DBMET01973 | ||
| 0.163 | 0.054 | 0.163 | Hemostatic | 0.129 0.098 DBMET01973 | ||
| 0.136 | 0.028 | 0.165 | Prolactin inhibitor | 0.165 0.017 DBMET01973 | DBMET01973 | |
| 0.191 | 0.083 | 0.191 | Insulin sensitizer | 0.166 0.112 DBMET01973 | ||
| 0.138 | 0.031 | 0.141 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.141 0.029 DBMET01973 | DBMET01973 | |
| 0.12 | 0.013 | 0.12 | Glycine receptor agonist | 0.09 0.028 DBMET01973 | ||
| 0.111 | 0.005 | 0.111 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.116 | 0.01 | 0.116 | 5 Hydroxytryptamine 3 agonist | 0.094 0.018 DBMET01973 | ||
| 0.194 | 0.088 | 0.194 | Interleukin antagonist | |||
| 0.134 | 0.03 | 0.136 | Catalase inhibitor | 0.136 0.029 DBMET01973 | DBMET01973 | |
| 0.138 | 0.034 | 0.138 | Carbonic anhydrase III inhibitor | 0.122 0.043 DBMET01973 | ||
| 0.126 | 0.026 | 0.126 | Histamine N-methyltransferase inhibitor | 0.118 0.031 DBMET01973 | ||
| 0.103 | 0.005 | 0.103 | Glucose-6-phosphate isomerase inhibitor | 0.082 0.008 DBMET01973 | ||
| 0.145 | 0.047 | 0.145 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.187 | 0.09 | 0.187 | Neurotrophic factor enhancer | 0.184 0.093 DBMET01973 | ||
| 0.106 | 0.009 | 0.106 | MAP kinase kinase 7 inhibitor | 0.089 0.026 DBMET01973 | ||
| 0.134 | 0.038 | 0.134 | Bronchodilator | |||
| 0.101 | 0.006 | 0.101 | Alpha-mannosidase inhibitor | 0.074 0.014 DBMET01973 | ||
| 0.111 | 0.016 | 0.112 | Biliverdin reductase inhibitor | 0.112 0.015 DBMET01973 | DBMET01973 | |
| 0.106 | 0.012 | 0.106 | Acetylcholine M1 receptor agonist | 0.102 0.012 DBMET01973 | ||
| 0.136 | 0.041 | 0.138 | Photosensitizer | 0.138 0.039 DBMET01973 | DBMET01973 | |
| 0.108 | 0.014 | 0.108 | Ornithine carbamoyltransferase inhibitor | 0.087 0.019 DBMET01973 | ||
| 0.104 | 0.012 | 0.104 | Nicotinic receptor alpha7 subunit antagonist | 0.09 0.014 DBMET01973 | ||
| 0.131 | 0.04 | 0.131 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.094 | 0.004 | 0.094 | Membrane dipeptidase inhibitor | 0.056 0.012 DBMET01973 | ||
| 0.133 | 0.043 | 0.133 | Expectorant | 0.103 0.065 DBMET01973 | ||
| 0.114 | 0.025 | 0.114 | Bile acid receptor antagonist | 0.11 0.031 DBMET01973 | ||
| 0.096 | 0.008 | 0.096 | Epithelial sodium channel blocker | 0.078 0.013 DBMET01973 | ||
| 0.117 | 0.031 | 0.117 | Carbonic anhydrase VI inhibitor | 0.087 0.049 DBMET01973 | ||
| 0.109 | 0.023 | 0.109 | Lipase inhibitor | 0.066 0.058 DBMET01973 | ||
| 0.172 | 0.088 | 0.172 | P-glycoprotein inhibitor | |||
| 0.124 | 0.041 | 0.124 | DOPA decarboxylase inhibitor | 0.124 0.041 DBMET01973 | ||
| 0.119 | 0.037 | 0.119 | Electrolyte absorption antagonist | 0.112 0.044 DBMET01973 | ||
| 0.086 | 0.004 | 0.086 | Geranyltranstransferase inhibitor | 0.066 0.009 DBMET01973 | ||
| 0.088 | 0.007 | 0.088 | Mannosidase inhibitor | 0.062 0.016 DBMET01973 | ||
| 0.14 | 0.06 | 0.14 | Toll-Like receptor 2 antagonist | 0.107 0.094 DBMET01973 | ||
| 0.13 | 0.051 | 0.143 | Cystathionine beta-synthase inhibitor | 0.143 0.044 DBMET01973 | DBMET01973 | |
| 0.117 | 0.038 | 0.117 | MAP kinase kinase 1 inhibitor | 0.085 0.079 DBMET01973 | ||
| 0.163 | 0.085 | 0.163 | Tumour necrosis factor antagonist | 0.133 0.122 DBMET01973 | ||
| 0.143 | 0.066 | 0.143 | Heat shock protein 70 antagonist | 0.136 0.091 DBMET01973 | ||
| 0.095 | 0.02 | 0.095 | GABA B receptor agonist | 0.09 0.026 DBMET01973 | ||
| 0.104 | 0.028 | 0.104 | Na+ K+ transporting ATPase inhibitor | 0.093 0.038 DBMET01973 | ||
| 0.086 | 0.012 | 0.088 | Aconitate hydratase inhibitor | 0.088 0.011 DBMET01973 | DBMET01973 | |
| 0.278 | 0.204 | 0.278 | MAP kinase 1 inhibitor | |||
| 0.08 | 0.008 | 0.08 | Retinoid X receptor agonist | 0.032 0.028 DBMET01973 | ||
| 0.144 | 0.072 | 0.144 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.09 | 0.018 | 0.09 | Antimetabolite | 0.046 0.034 DBMET01973 | ||
| 0.089 | 0.017 | 0.089 | Interferon inducer | |||
| 0.076 | 0.005 | 0.076 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.031 0.029 DBMET01973 | ||
| 0.111 | 0.042 | 0.111 | Antineoplastic alkaloid | |||
| 0.074 | 0.007 | 0.084 | Acetylcholine M4 receptor agonist | 0.084 0.005 DBMET01973 | DBMET01973 | |
| 0.094 | 0.027 | 0.094 | Fibroblast growth factor 2 antagonist | |||
| 0.074 | 0.009 | 0.074 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.069 | 0.005 | 0.069 | Carnitine palmitoyltransferase 1A inhibitor | 0.028 0.02 DBMET01973 | ||
| 0.125 | 0.061 | 0.125 | Cholesterol synthesis inhibitor | 0.105 0.081 DBMET01973 | ||
| 0.107 | 0.043 | 0.107 | Calcium antagonist | 0.091 0.055 DBMET01973 | ||
| 0.103 | 0.039 | 0.125 | Glutamate release inhibitor | 0.125 0.019 DBMET01973 | DBMET01973 | |
| 0.087 | 0.024 | 0.087 | NMDA receptor glycine site agonist | 0.076 0.031 DBMET01973 | ||
| 0.148 | 0.085 | 0.148 | Melanin inhibitor | |||
| 0.082 | 0.021 | 0.082 | Carbonic anhydrase VB inhibitor | 0.063 0.033 DBMET01973 | ||
| 0.077 | 0.017 | 0.077 | Glucosylceramidase inhibitor | |||
| 0.071 | 0.011 | 0.089 | Adenylate cyclase 1 inhibitor | 0.089 0.005 DBMET01973 | DBMET01973 | |
| 0.081 | 0.023 | 0.085 | Glutamate (mGluR6) antagonist | 0.085 0.019 DBMET01973 | DBMET01973 | |
| 0.084 | 0.026 | 0.084 | NMDA receptor agonist | 0.066 0.04 DBMET01973 | ||
| 0.089 | 0.031 | 0.089 | Calcium channel L-type blocker | |||
| 0.087 | 0.03 | 0.09 | Vanilloid 4 agonist | 0.09 0.026 DBMET01973 | DBMET01973 | |
| 0.131 | 0.075 | 0.131 | Bone formation stimulant | |||
| 0.184 | 0.129 | 0.184 | Hypoglycemic | |||
| 0.095 | 0.04 | 0.095 | Carbonic anhydrase XIII inhibitor | |||
| 0.096 | 0.041 | 0.099 | Granulocyte macrophage colony stimulating factor agonist | 0.099 0.036 DBMET01973 | DBMET01973 | |
| 0.163 | 0.109 | 0.163 | MAP kinase kinase 2 inhibitor | |||
| 0.079 | 0.026 | 0.085 | Argininosuccinate synthase inhibitor | 0.085 0.023 DBMET01973 | DBMET01973 | |
| 0.089 | 0.036 | 0.112 | GABA aminotransferase inhibitor | 0.112 0.02 DBMET01973 | DBMET01973 | |
| 0.094 | 0.041 | 0.096 | mTOR complex 2 inhibitor | 0.096 0.039 DBMET01973 | DBMET01973 | |
| 0.067 | 0.015 | 0.067 | Squalene epoxidase inhibitor | 0.05 0.034 DBMET01973 | ||
| 0.057 | 0.005 | 0.057 | Urotensin II agonist | |||
| 0.128 | 0.076 | 0.128 | Amylase inhibitor | |||
| 0.094 | 0.043 | 0.094 | Glutathione S-transferase inhibitor | |||
| 0.141 | 0.09 | 0.142 | Interferon gamma antagonist | 0.142 0.089 DBMET01973 | DBMET01973 | |
| 0.069 | 0.018 | 0.069 | Toll-Like receptor 2 agonist | 0.042 0.028 DBMET01973 | ||
| 0.055 | 0.004 | 0.055 | Adenosine uptake inhibitor | 0.048 0.005 DBMET01973 | ||
| 0.164 | 0.113 | 0.164 | Anticonvulsant | |||
| 0.061 | 0.011 | 0.061 | Phosphoglycerate kinase inhibitor | |||
| 0.055 | 0.006 | 0.055 | Carnitine palmitoyltransferase inhibitor | 0.036 0.021 DBMET01973 | ||
| 0.053 | 0.005 | 0.053 | Ceramide glucosyltransferase inhibitor | 0.046 0.01 DBMET01973 | ||
| 0.069 | 0.022 | 0.069 | Sphingosine kinase 2 inhibitor | 0.054 0.04 DBMET01973 | ||
| 0.05 | 0.003 | 0.05 | Estrogen-related receptor gamma antagonist | 0.03 0.016 DBMET01973 | ||
| 0.171 | 0.125 | 0.171 | Platelet antagonist | |||
| 0.071 | 0.024 | 0.071 | Sphingosine kinase inhibitor | |||
| 0.09 | 0.043 | 0.09 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.053 | 0.006 | 0.053 | Carnitine palmitoyltransferase 1 inhibitor | 0.035 0.021 DBMET01973 | ||
| 0.057 | 0.011 | 0.057 | GABA uptake inhibitor | 0.036 0.033 DBMET01973 | ||
| 0.108 | 0.063 | 0.165 | Falcipain 3 inhibitor | 0.165 0.03 DBMET01973 | DBMET01973 | |
| 0.087 | 0.041 | 0.087 | Keratolytic | |||
| 0.058 | 0.013 | 0.058 | Guanylate cyclase inhibitor | 0.05 0.021 DBMET01973 | ||
| 0.073 | 0.029 | 0.073 | Nitric oxide donor | |||
| 0.047 | 0.003 | 0.056 | Vanilloid 2 agonist | 0.056 0.002 DBMET01973 | DBMET01973 | |
| 0.056 | 0.012 | 0.056 | Arginase inhibitor | 0.041 0.021 DBMET01973 | ||
| 0.051 | 0.009 | 0.051 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.029 0.019 DBMET01973 | ||
| 0.061 | 0.02 | 0.061 | Adenosine deaminase inhibitor | |||
| 0.127 | 0.086 | 0.127 | Protein kinase stimulant | 0.116 0.097 DBMET01973 | ||
| 0.075 | 0.034 | 0.102 | Exportin-1 inhibitor | 0.102 0.008 DBMET01973 | DBMET01973 | |
| 0.064 | 0.023 | 0.064 | Glycine transporter 2 inhibitor | |||
| 0.061 | 0.022 | 0.061 | Immunoglobulin Fc receptor antagonist | 0.058 0.03 DBMET01973 | ||
| 0.067 | 0.027 | 0.067 | Beta 2 adrenoreceptor agonist | 0.059 0.055 DBMET01973 | ||
| 0.081 | 0.042 | 0.081 | Histidine decarboxylase inhibitor | 0.074 0.047 DBMET01973 | ||
| 0.052 | 0.013 | 0.054 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.054 0.011 DBMET01973 | DBMET01973 | |
| 0.092 | 0.054 | 0.092 | Ornithine decarboxylase inhibitor | 0.089 0.057 DBMET01973 | ||
| 0.047 | 0.009 | 0.047 | Bradykinin B2 receptor antagonist | |||
| 0.078 | 0.041 | 0.089 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.089 0.023 DBMET01973 | DBMET01973 | |
| 0.057 | 0.02 | 0.057 | Thymidylate synthase inhibitor | |||
| 0.048 | 0.013 | 0.048 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.036 0.026 DBMET01973 | ||
| 0.084 | 0.05 | 0.111 | Glycine receptor antagonist | 0.111 0.024 DBMET01973 | DBMET01973 | |
| 0.052 | 0.018 | 0.052 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.044 | 0.01 | 0.044 | Uridine phosphorylase inhibitor | |||
| 0.109 | 0.075 | 0.142 | Microtubule formation inhibitor | 0.142 0.042 DBMET01973 | DBMET01973 | |
| 0.274 | 0.241 | 0.274 | Antiinflammatory | |||
| 0.074 | 0.042 | 0.074 | Carbonic anhydrase VA inhibitor | |||
| 0.047 | 0.015 | 0.049 | Fumarate hydratase inhibitor | 0.049 0.014 DBMET01973 | DBMET01973 | |
| 0.208 | 0.176 | 0.208 | Interleukin 2 agonist | |||
| 0.054 | 0.023 | 0.08 | Cholesterol esterase inhibitor | 0.08 0.007 DBMET01973 | DBMET01973 | |
| 0.092 | 0.062 | 0.092 | HIV-1 integrase (Overall Integration) inhibitor | 0.084 0.072 DBMET01973 | ||
| 0.114 | 0.084 | 0.133 | Cyclooxygenase 3 inhibitor | 0.133 0.064 DBMET01973 | DBMET01973 | |
| 0.048 | 0.019 | 0.048 | Sphingosine kinase 1 inhibitor | |||
| 0.036 | 0.007 | 0.036 | Lysophosphatidic acid receptor 1 agonist | 0.033 0.008 DBMET01973 | ||
| 0.099 | 0.071 | 0.099 | Topoisomerase I inhibitor | |||
| 0.07 | 0.043 | 0.07 | Carbonic anhydrase V inhibitor | 0.063 0.05 DBMET01973 | ||
| 0.085 | 0.058 | 0.085 | Myeloperoxidase inhibitor | |||
| 0.08 | 0.053 | 0.08 | Topoisomerase II alpha inhibitor | |||
| 0.05 | 0.024 | 0.05 | Sphingosine 1-phosphate receptor agonist | |||
| 0.046 | 0.02 | 0.051 | Kainate receptor agonist | 0.051 0.013 DBMET01973 | DBMET01973 | |
| 0.071 | 0.045 | 0.071 | Protein kinase C beta inhibitor | 0.066 0.056 DBMET01973 | ||
| 0.211 | 0.186 | 0.211 | Immunosuppressant | |||
| 0.134 | 0.109 | 0.164 | CF transmembrane conductance regulator agonist | 0.164 0.054 DBMET01973 | DBMET01973 | |
| 0.046 | 0.022 | 0.046 | Thymidine kinase inhibitor | |||
| 0.053 | 0.029 | 0.053 | Topoisomerase II beta inhibitor | 0.052 0.03 DBMET01973 | ||
| 0.037 | 0.014 | 0.037 | Estrogen-related receptor beta antagonist | |||
| 0.062 | 0.04 | 0.078 | Purinergic P2X1 antagonist | 0.078 0.026 DBMET01973 | DBMET01973 | |
| 0.141 | 0.119 | 0.141 | Lipocortins synthesis antagonist | |||
| 0.042 | 0.02 | 0.046 | Glutamate (mGluR8) agonist | 0.046 0.014 DBMET01973 | DBMET01973 | |
| 0.042 | 0.02 | 0.042 | CF transmembrane conductance regulator antagonist | |||
| 0.094 | 0.073 | 0.112 | Glutamate (mGluR7) agonist | 0.112 0.04 DBMET01973 | DBMET01973 | |
| 0.025 | 0.005 | 0.025 | Nicotinic alpha4 receptor agonist | 0.023 0.005 DBMET01973 | ||
| 0.033 | 0.013 | 0.036 | Purinergic P2Y15 antagonist | 0.036 0.01 DBMET01973 | DBMET01973 | |
| 0.031 | 0.012 | 0.031 | 1,3-Beta-glucan synthase inhibitor | |||
| 0.056 | 0.037 | 0.056 | Ribonucleoside-diphosphate reductase inhibitor | 0.045 0.044 DBMET01973 | ||
| 0.099 | 0.079 | 0.099 | Protein kinase C gamma inhibitor | |||
| 0.117 | 0.097 | 0.117 | Lipid peroxidase inhibitor | |||
| 0.057 | 0.038 | 0.057 | Ribonucleotide reductase inhibitor | 0.046 0.045 DBMET01973 | ||
| 0.031 | 0.012 | 0.031 | Calcium-sensing receptor agonist | |||
| 0.067 | 0.048 | 0.101 | Glutamate (mGluR7) antagonist | 0.101 0.01 DBMET01973 | DBMET01973 | |
| 0.087 | 0.068 | 0.087 | Alcohol dehydrogenase inhibitor | |||
| 0.03 | 0.012 | 0.031 | Hedgehog signaling activator | 0.031 0.012 DBMET01973 | DBMET01973 | |
| 0.024 | 0.006 | 0.024 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET01973 | ||
| 0.052 | 0.034 | 0.052 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.118 | 0.1 | 0.12 | Nav1.6 sodium channel blocker | 0.12 0.096 DBMET01973 | DBMET01973 | |
| 0.032 | 0.014 | 0.032 | Lysine carboxypeptidase inhibitor | 0.025 0.021 DBMET01973 | ||
| 0.064 | 0.046 | 0.064 | Beta 3 adrenoreceptor antagonist | |||
| 0.078 | 0.06 | 0.078 | Adrenaline agonist | |||
| 0.063 | 0.046 | 0.064 | Calcium channel P-type blocker | 0.064 0.042 DBMET01973 | DBMET01973 | |
| 0.04 | 0.024 | 0.05 | Diamine oxidase inhibitor | 0.05 0.015 DBMET01973 | DBMET01973 | |
| 0.034 | 0.018 | 0.037 | Glutamate (mGluR3) agonist | 0.037 0.014 DBMET01973 | DBMET01973 | |
| 0.056 | 0.04 | 0.057 | Pregnane X receptor antagonist | 0.057 0.037 DBMET01973 | DBMET01973 | |
| 0.021 | 0.005 | 0.021 | Lysophosphatidic acid receptor 3 agonist | 0.02 0.005 DBMET01973 | ||
| 0.041 | 0.025 | 0.041 | Dihydropteroate synthase inhibitor | |||
| 0.048 | 0.033 | 0.05 | Cytokine production stimulant | 0.05 0.03 DBMET01973 | DBMET01973 | |
| 0.064 | 0.049 | 0.064 | Beta adrenoreceptor antagonist | |||
| 0.022 | 0.007 | 0.022 | Estrogen-related receptor gamma agonist | |||
| 0.043 | 0.029 | 0.043 | Oxytocin agonist | 0.04 0.032 DBMET01973 | ||
| 0.11 | 0.096 | 0.119 | DNA repair enzyme inhibitor | 0.119 0.074 DBMET01973 | DBMET01973 | |
| 0.028 | 0.014 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.05 | 0.036 | 0.063 | Lysophosphatidic acid 3 receptor antagonist | 0.063 0.019 DBMET01973 | DBMET01973 | |
| 0.109 | 0.096 | 0.109 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.04 | 0.027 | 0.043 | Dopamine D5 agonist | 0.043 0.024 DBMET01973 | DBMET01973 | |
| 0.088 | 0.075 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | 0.101 0.054 DBMET01973 | DBMET01973 | |
| 0.052 | 0.039 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.02 | 0.008 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.012 DBMET01973 | ||
| 0.02 | 0.009 | 0.022 | Carbonic anhydrase X inhibitor | 0.022 0.007 DBMET01973 | DBMET01973 | |
| 0.02 | 0.009 | 0.022 | Carbonic anhydrase VIII inhibitor | 0.022 0.007 DBMET01973 | DBMET01973 | |
| 0.098 | 0.088 | 0.098 | Topoisomerase II inhibitor | |||
| 0.045 | 0.036 | 0.045 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.014 | 0.005 | 0.014 | Immunosuppressant Cyclosporine-like | 0.011 0.009 DBMET01973 | ||
| 0.123 | 0.114 | 0.123 | Hexokinase inhibitor | |||
| 0.109 | 0.101 | 0.109 | Alkaline phosphatase inhibitor | |||
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.046 | 0.039 | 0.046 | Bromodomain-containing protein 3 inhibitor | |||
| 0.023 | 0.015 | 0.023 | Prostaglandin F2 alpha agonist | |||
| 0.011 | 0.004 | 0.011 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.018 | 0.011 | 0.018 | Ileal bile acid transport inhibitor | |||
| 0.079 | 0.073 | 0.089 | D-Ala-D-Ala ligase inhibitor | 0.089 0.047 DBMET01973 | DBMET01973 | |
| 0.064 | 0.058 | 0.064 | MDM2 inhibitor | |||
| 0.026 | 0.019 | 0.026 | Thymidine phosphorylase inhibitor | |||
| 0.021 | 0.015 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.049 | 0.044 | 0.049 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.013 | 0.009 | 0.016 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.016 0.006 DBMET01973 | DBMET01973 | |
| 0.045 | 0.042 | 0.045 | Bombesin 2 receptor antagonist | |||
| 0.016 | 0.013 | 0.018 | Telomerase stimulant | 0.018 0.011 DBMET01973 | DBMET01973 | |
| 0.021 | 0.019 | 0.021 | Isoleucine-tRNA ligase inhibitor | |||
| 0.087 | 0.085 | 0.087 | Phosphodiesterase 6D inhibitor | |||
| 0.016 | 0.014 | 0.016 | Vitamin D receptor agonist | |||
| 0.031 | 0.029 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.016 | 0.015 | 0.016 | Cyclin T1 inhibitor | |||
| 0.024 | 0.023 | 0.024 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.025 | 0.024 | 0.025 | LFA antagonist | |||
| 0.217 | 0.216 | 0.217 | Analgesic | |||
| 0.014 | 0.013 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.013 DBMET01973 | DBMET01973 | |
| 0.052 | 0.051 | 0.052 | Cannabinoid CB1 receptor agonist | |||
| 0.036 | 0.035 | 0.037 | Glutamate (mGluR1a) antagonist | 0.037 0.033 DBMET01973 | DBMET01973 | |
| 0.045 | 0.044 | 0.045 | Dopamine beta hydroxylase inhibitor | 0.045 0.042 DBMET01973 | ||
| 0.024 | 0.024 | 0.029 | Integrin alpha2beta1 antagonist | 0.029 0.014 DBMET01973 | DBMET01973 | |
| 0.068 | 0.07 | 0.073 | Potassium channel (Tandem pore domain) blocker | 0.073 0.055 DBMET01973 | DBMET01973 | |
| 0.016 | 0.019 | 0.02 | CXC chemokine 5 receptor antagonist | 0.02 0.009 DBMET01973 | DBMET01973 | |
| 0.032 | 0.036 | 0.039 | Integrin alpha2 antagonist | 0.039 0.022 DBMET01973 | DBMET01973 | |
| 0.018 | 0.024 | 0.033 | Glutamate (mGluR1a) agonist | 0.033 0.007 DBMET01973 | DBMET01973 | |
| 0.035 | 0.043 | 0.051 | Histamine H2 receptor agonist | 0.051 0.02 DBMET01973 | DBMET01973 | |
| 0.048 | 0.059 | 0.056 | Carbonic anhydrase stimulant | 0.056 0.045 DBMET01973 | DBMET01973 | |
| 0.022 | 0.036 | 0.027 | Peptide deformylase inhibitor | 0.027 0.025 DBMET01973 | DBMET01973 | |
| 0.038 | 0.052 | 0.043 | CC chemokine 4 receptor antagonist | 0.043 0.041 DBMET01973 | DBMET01973 | |
| 0.02 | 0.035 | 0.037 | Nicotinic alpha4beta2 receptor agonist | 0.037 0.01 DBMET01973 | DBMET01973 | |
| 0.037 | 0.052 | 0.049 | Histamine H1 receptor agonist | 0.049 0.02 DBMET01973 | DBMET01973 | |
| 0.021 | 0.037 | 0.03 | Acid ceramidase inhibitor | 0.03 0.009 DBMET01973 | DBMET01973 | |
| 0.019 | 0.036 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.01 DBMET01973 | DBMET01973 | |
| 0.046 | 0.064 | 0.054 | Dihydroorotate oxidase inhibitor | 0.054 0.041 DBMET01973 | DBMET01973 | |
| 0.028 | 0.048 | 0.04 | Alpha 1d adrenoreceptor agonist | 0.04 0.025 DBMET01973 | DBMET01973 | |
| 0.051 | 0.074 | 0.082 | Protease 3C (Human rhinovirus) inhibitor | 0.082 0.025 DBMET01973 | DBMET01973 | |
| 0.117 | 0.14 | 0.137 | Pregnane X receptor agonist | 0.137 0.082 DBMET01973 | DBMET01973 | |
| 0.024 | 0.048 | 0.032 | Dipeptidyl peptidase II inhibitor | 0.032 0.024 DBMET01973 | DBMET01973 | |
| 0.005 | 0.029 | 0.01 | Angiotensin AT2 receptor agonist | 0.01 0.008 DBMET01973 | DBMET01973 | |
| 0.073 | 0.098 | 0.089 | ATPase (Vacuolar H+) inhibitor | 0.089 0.058 DBMET01973 | DBMET01973 | |
| 0.033 | 0.059 | 0.045 | Nerve growth factor antagonist | 0.045 0.026 DBMET01973 | DBMET01973 | |
| 0.027 | 0.053 | 0.04 | Vascular adhesion protein 1 inhibitor | 0.04 0.025 DBMET01973 | DBMET01973 | |
| 0.039 | 0.07 | 0.061 | Elastase inhibitor | 0.061 0.029 DBMET01973 | DBMET01973 | |
| 0.066 | 0.099 | 0.076 | Histamine H2 receptor antagonist | 0.076 0.074 DBMET01973 | DBMET01973 | |
| 0.006 | 0.039 | 0.009 | CXC chemokine 3 receptor agonist | 0.009 0.008 DBMET01973 | DBMET01973 | |
| 0.071 | 0.109 | 0.08 | CC chemokine 5 receptor agonist | 0.08 0.065 DBMET01973 | DBMET01973 | |
| 0.054 | 0.092 | 0.085 | Nicotinic alpha4beta2 receptor antagonist | 0.085 0.045 DBMET01973 | DBMET01973 | |
| 0.053 | 0.095 | 0.079 | CYP2A6 inhibitor | 0.079 0.05 DBMET01973 | DBMET01973 | |
| 0.048 | 0.093 | 0.072 | Amidase inhibitor | 0.072 0.046 DBMET01973 | DBMET01973 | |
| 0.07 | 0.122 | 0.086 | Interleukin 1 beta converting enzyme inhibitor | 0.086 0.08 DBMET01973 | DBMET01973 | |
| 0.012 | 0.067 | 0.023 | Protease (Human cytomegalovirus) inhibitor | 0.023 0.014 DBMET01973 | DBMET01973 | |
| 0.062 | 0.118 | 0.075 | Caspase 7 inhibitor | 0.075 0.074 DBMET01973 | DBMET01973 | |
| 0.07 | 0.127 | 0.122 | 5 Hydroxytryptamine 3A agonist | 0.122 0.054 DBMET01973 | DBMET01973 | |
| 0.023 | 0.08 | 0.042 | Oleamide hydrolase inhibitor | 0.042 0.035 DBMET01973 | DBMET01973 | |
| 0.141 | 0.204 | 0.209 | 5 Hydroxytryptamine 1E antagonist | 0.209 0.121 DBMET01973 | DBMET01973 | |
| 0.013 | 0.079 | 0.031 | Nicotinic alpha3beta4 receptor agonist | 0.031 0.02 DBMET01973 | DBMET01973 | |
| 0.041 | 0.107 | 0.067 | Potassium channel intermediate-conductance Ca-activated blocker | 0.067 0.03 DBMET01973 | DBMET01973 | |
| 0.03 | 0.102 | 0.046 | Prolyl endopeptidase inhibitor | 0.046 0.043 DBMET01973 | DBMET01973 | |
| 0.012 | 0.085 | 0.021 | Factor XIII inhibitor | 0.021 0.014 DBMET01973 | DBMET01973 | |
| 0.031 | 0.109 | 0.049 | HCV NS3/NS4A protease inhibitor | 0.049 0.034 DBMET01973 | DBMET01973 | |
| 0.046 | 0.126 | 0.06 | Histone deacetylase SIRT3 inhibitor | 0.06 0.049 DBMET01973 | DBMET01973 | |
| 0.018 | 0.101 | 0.026 | Glucosylceramidase stimulant | 0.026 0.024 DBMET01973 | DBMET01973 | |
| 0.012 | 0.098 | 0.033 | Potassium channel small-conductance Ca-activated activator | 0.033 0.02 DBMET01973 | DBMET01973 | |
| 0.027 | 0.118 | 0.047 | Benzodiazepine antagonist | 0.047 0.033 DBMET01973 | DBMET01973 | |
| 0.045 | 0.148 | 0.06 | Transcription factor RelA inhibitor | 0.06 0.057 DBMET01973 | DBMET01973 | |
| 0.096 | 0.234 | 0.165 | 3C-like protease (Human coronavirus) inhibitor | 0.165 0.079 DBMET01973 | DBMET01973 | |
| 0.05 | 0.246 | 0.096 | Nav1.4 sodium channel blocker | 0.096 0.083 DBMET01973 | DBMET01973 | |
| 0.085 | 0.289 | 0.171 | Calpain inhibitor | 0.171 0.146 DBMET01973 | DBMET01973 | |
| 0.093 | 0.321 | 0.198 | Calpain 2 inhibitor | 0.198 0.19 DBMET01973 | DBMET01973 | |
| 0.061 | 0.307 | 0.107 | Factor V inhibitor | 0.107 0.056 DBMET01973 | DBMET01973 | |
| 0.005 | 0.601 | 0.037 | Factor XIa inhibitor | 0.037 0.033 DBMET01973 | DBMET01973 | |
| 0.002 | 0.954 | 0.035 | HCV NS5A inhibitor | 0.035 0.009 DBMET01973 | DBMET01973 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |